Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Theragenics bags Deal

This article was originally published in The Gray Sheet

Executive Summary

Federal and state government bodies should ensure that prostate cancer patients are able to obtain "readily understandable descriptions" of the risks and benefits of "all medically efficacious treatments" for the condition, "including brachytherapy...external beam radiation" and other options, a June 14 House resolution (H Res 669) declares. Sponsored by Rep. Nathan Deal (R-Ga.), whose district includes brachytherapy seed maker Theragenics, the resolution was timed to coincide with National Men's Health Week, which concludes on Father's Day June 20...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT020445

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel